University of Medicine and Pharmacy Hospital, Ho Chi Minh City receives JCI certification for the PRIME program on preventing infection risk and medication errors in intravenous therapy (PRIME JCI)
On February 24, 2025, the University of Medicine and Pharmacy Hospital of Ho Chi Minh City (BV ĐHYD) officially received JCI certification for the “Prevention of Infection Risk and Medication Errors in Intravenous Therapy (PRIME)” program. This is an important step forward in the journey to improve the quality of care and patient safety according to the practice standards of the International Committee for Patient Safety (JCI Organization).
Speaking at the ceremony, Assoc. Prof. Dr. Nguyễn Hoàng Bắc – Director of ĐHYD Hospital said: “The hospital sincerely thanks the advisors from the JCI organization and the experts from BD Company who have accompanied the PRIME program. The achievements obtained are proof of the spirit of unity and continuous effort of the Hospital staff in maintaining, improving, and ensuring international standards for patient safety. We are committed to continue innovating, moving towards a standard, advanced, and distinctive care model, creating sustainable value for the community and enhancing patient safety levels.”
According to Dr. Nguyễn Thị Hồng Minh – Head of the Hospital Nursing Department, ĐHYD Hospital is the first university hospital in Vietnam and Southeast Asia to successfully implement the PRIME JCI program with a scale of 1,000 participating nurses. It is also a pioneering hospital with the largest implementation scale nationwide, almost fully meeting the requirements of the JCI organization. This success is due to the determination and support of the Hospital Management Board, the unity of the leaders of the Departments/Units, and the effort of each Hospital staff member.
Dr. Jeannell M. Mansur – Senior Advisor of the JCI Organization, Director of the PRIME JCI program sends congratulations to ĐHYD Hospital. “From the very first days of implementation, the Hospital has affirmed its strong determination and commitment to comply with and actualize JCI standards in care practice. I am confident that the Hospital will not only maintain but also continuously update, improve, and develop the program, expand its application scope, enhance practical effectiveness, contributing to building a safe, quality, and sustainable healthcare environment.”
Dr. Monnie Abraham – Advisor of JCI Organization, primarily responsible for evaluating monthly results of the PRIME JCI program at BV ĐHYD, states: “The hospital not only strictly adheres to the program’s requirements but also proactively sets higher standards for continuous improvement. With a large and well-qualified staff, this is a crucial foundation contributing to the hospital’s success in this program.”
The implementation of the PRIME program according to the standards of the JCI Organization is an important international certification, affirming the quality of safe and professional patient care at ĐHYD Hospital. The PRIME program is tightly controlled from the initial stage of infusion therapy, including the selection of appropriate equipment, vascular access techniques such as locating the site, skin preparation, catheter placement, fixation, locking, and maintaining the line. At the same time, the program ensures that the drug preparation process meets standards, from the environment, professional techniques, dosage calculations to safety when handling hazardous drugs. Medication use management is carried out strictly, from pharmacist‑approved indications, infusion rate calculations to responsibility for post‑administration monitoring. Additionally, the program also focuses on controlling unwanted outcomes such as preventing hospital‑acquired infections and medication errors, aiming to improve patient safety.
The program has been implemented in more than 50 hospitals worldwide, PRIME has become an international healthcare standard, and ĐHYD Hospital is proud to have received this prestigious certification. This success further reinforces the Hospital's commitment to continuous innovation, improving treatment quality, and delivering healthcare services that meet international standards, safe and effective.
Presenting the certification to PRIME Champions:
